lilly 51641 has been researched along with harmaline in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fuller, RW; Hemrick-Luecke, SK; Molloy, BB | 1 |
| Fuller, RW; Hemrick-Luecke, SK | 1 |
2 other study(ies) available for lilly 51641 and harmaline
| Article | Year |
|---|---|
N-[2-(o-iodophenoxy)ethyl]cyclopropylamine hydrochloride (LY121768), a potent and selective irreversible inhibitor of type A monoamine oxidase.
Topics: Animals; Brain; Cyclopropanes; Dose-Response Relationship, Drug; Harmaline; Kinetics; Male; Mitochondria; Mitochondria, Liver; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Myocardium; Rats; Rats, Inbred Strains | 1983 |
Elevation of epinephrine concentration in rat brain by LY51641, a selective inhibitor of type A monoamine oxidase.
Topics: Animals; Blood Pressure; Brain Chemistry; Cyclopropanes; Dose-Response Relationship, Drug; Epinephrine; Harmaline; Hypothalamus; Male; Monoamine Oxidase Inhibitors; Neurons; Pargyline; Phenyl Ethers; Rats | 1981 |